img

Recombinant Vaccines


Published on: 2024-01-04 | No of Pages : 129 | Industry : Pharma & Healthcare

Publisher : HNY Research | Format : PDF&Excel

Recombinant Vaccines

The global Recombinant Vaccines market was valued at 802.28 Million USD in 2021 and will grow with a CAGR of 3.36% from 2021 to 2027, based on HNY Research newly published report.

The prime objective of this report is to provide the insights on the post COVID-19 impact wwhich will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

Recombinant vaccines are produced using recombinant DNA technology, with the help of a vector. These vaccines stimulate the immune system of an individual and provide immunity against various lethal disease. These vaccines are safe and have less or no side-effects as compared to conventional vaccines, in the prevention of various diseases such as influenza, cholera, typhoid, and dengue. Recombinant vaccines are also used in animals for prevention of diseases such as foot and mouth disease, pneumonia and septicemia, and pox disease. Vaccination results in the prevention of disease, by producing antibodies against the protein antigen of pathogenic microorganisms. There is increase in the demand for livestock products, which in turn has increased growth of the animal recombinant vaccine segment and Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and huge demand of livestock product for the European population.

By Market Verdors

Merck & Co., Inc

Green Cross Corporation

Pfizer Inc.

Bayer AG

Sanofi S A.

Protein Science Corporation

GlaxoSmithKline Plc.

Novartis AG

Bharat Biotech



By Types

Subunit Recombinant Vaccines

Attenuated Recombinant Vaccines

Vector Recombinant Vaccines



By Applications

Recombinant Human Vaccines

Animal Recombinant Vaccines



Key Indicators Analysed

Market Players & Competitor AnalysisThe report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.

Global and Regional Market AnalysisThe report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.

Market TrendsMarket key trends which include Increased Competition and Continuous Innovations.

Opportunities and DriversIdentifying the Growing Demands and New Technology

Porters Five Force AnalysisThe report provides with the state of competition in industry depending on five basic forcesthreat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.



Key Reasons to Purchase

To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements

Table of Content

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Recombinant Vaccines Revenue

1.4 Market Analysis by Type

1.4.1 Global Recombinant Vaccines Market Size Growth Rate by Type: 2021 VS 2027

1.4.2 Subunit Recombinant Vaccines

1.4.3 Attenuated Recombinant Vaccines

1.4.4 Vector Recombinant Vaccines

1.5 Market by Application

1.5.1 Global Recombinant Vaccines Market Share by Application: 2022-2027

1.5.2 Recombinant Human Vaccines

1.5.3 Animal Recombinant Vaccines

1.6 Study Objectives

1.7 Years Considered

1.8 Overview of Global Recombinant Vaccines Market

1.8.1 Global Recombinant Vaccines Market Status and Outlook (2016-2027)

1.8.2 North America

1.8.3 East Asia

1.8.4 Europe

1.8.5 South Asia

1.8.6 Southeast Asia

1.8.7 Middle East

1.8.8 Africa

1.8.9 Oceania

1.8.10 South America

1.8.11 Rest of the World

2 Market Competition by Manufacturers

2.1 Global Recombinant Vaccines Production Capacity Market Share by Manufacturers (2016-2021)

2.2 Global Recombinant Vaccines Revenue Market Share by Manufacturers (2016-2021)

2.3 Global Recombinant Vaccines Average Price by Manufacturers (2016-2021)

2.4 Manufacturers Recombinant Vaccines Production Sites, Area Served, Product Type

3 Sales by Region

3.1 Global Recombinant Vaccines Sales Volume Market Share by Region (2016-2021)

3.2 Global Recombinant Vaccines Sales Revenue Market Share by Region (2016-2021)

3.3 North America Recombinant Vaccines Sales Volume

3.3.1 North America Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

3.3.2 North America Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 East Asia Recombinant Vaccines Sales Volume

3.4.1 East Asia Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

3.4.2 East Asia Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Europe Recombinant Vaccines Sales Volume (2016-2021)

3.5.1 Europe Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

3.5.2 Europe Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 South Asia Recombinant Vaccines Sales Volume (2016-2021)

3.6.1 South Asia Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

3.6.2 South Asia Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Southeast Asia Recombinant Vaccines Sales Volume (2016-2021)

3.7.1 Southeast Asia Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

3.7.2 Southeast Asia Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Middle East Recombinant Vaccines Sales Volume (2016-2021)

3.8.1 Middle East Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

3.8.2 Middle East Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Africa Recombinant Vaccines Sales Volume (2016-2021)

3.9.1 Africa Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

3.9.2 Africa Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Oceania Recombinant Vaccines Sales Volume (2016-2021)

3.10.1 Oceania Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

3.10.2 Oceania Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 South America Recombinant Vaccines Sales Volume (2016-2021)

3.11.1 South America Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

3.11.2 South America Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Rest of the World Recombinant Vaccines Sales Volume (2016-2021)

3.12.1 Rest of the World Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

3.12.2 Rest of the World Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

4 North America

4.1 North America Recombinant Vaccines Consumption by Countries

4.2 United States

4.3 Canada

4.4 Mexico

5 East Asia

5.1 East Asia Recombinant Vaccines Consumption by Countries

5.2 China

5.3 Japan

5.4 South Korea

6 Europe

6.1 Europe Recombinant Vaccines Consumption by Countries

6.2 Germany

6.3 United Kingdom

6.4 France

6.5 Italy

6.6 Russia

6.7 Spain

6.8 Netherlands

6.9 Switzerland

6.10 Poland

7 South Asia

7.1 South Asia Recombinant Vaccines Consumption by Countries

7.2 India

7.3 Pakistan

7.4 Bangladesh

8 Southeast Asia

8.1 Southeast Asia Recombinant Vaccines Consumption by Countries

8.2 Indonesia

8.3 Thailand

8.4 Singapore

8.5 Malaysia

8.6 Philippines

8.7 Vietnam

8.8 Myanmar

9 Middle East

9.1 Middle East Recombinant Vaccines Consumption by Countries

9.2 Turkey

9.3 Saudi Arabia

9.4 Iran

9.5 United Arab Emirates

9.6 Israel

9.7 Iraq

9.8 Qatar

9.9 Kuwait

9.10 Oman

10 Africa

10.1 Africa Recombinant Vaccines Consumption by Countries

10.2 Nigeria

10.3 South Africa

10.4 Egypt

10.5 Algeria

10.6 Morocco

11 Oceania

11.1 Oceania Recombinant Vaccines Consumption by Countries

11.2 Australia

11.3 New Zealand

12 South America

12.1 South America Recombinant Vaccines Consumption by Countries

12.2 Brazil

12.3 Argentina

12.4 Columbia

12.5 Chile

12.6 Venezuela

12.7 Peru

12.8 Puerto Rico

12.9 Ecuador

13 Rest of the World

13.1 Rest of the World Recombinant Vaccines Consumption by Countries

13.2 Kazakhstan

14 Sales Volume, Sales Revenue, Sales Price Trend by Type

14.1 Global Recombinant Vaccines Sales Volume Market Share by Type (2016-2021)

14.2 Global Recombinant Vaccines Sales Revenue Market Share by Type (2016-2021)

14.3 Global Recombinant Vaccines Sales Price by Type (2016-2021)

15 Consumption Analysis by Application

15.1 Global Recombinant Vaccines Consumption Volume by Application (2016-2021)

15.2 Global Recombinant Vaccines Consumption Value by Application (2016-2021)

16 Company Profiles and Key Figures in Recombinant Vaccines Business

16.1 Merck & Co., Inc

16.1.1 Merck & Co., Inc Company Profile

16.1.2 Merck & Co., Inc Recombinant Vaccines Product Specification

16.1.3 Merck & Co., Inc Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.2 Green Cross Corporation

16.2.1 Green Cross Corporation Company Profile

16.2.2 Green Cross Corporation Recombinant Vaccines Product Specification

16.2.3 Green Cross Corporation Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.3 Pfizer Inc.

16.3.1 Pfizer Inc. Company Profile

16.3.2 Pfizer Inc. Recombinant Vaccines Product Specification

16.3.3 Pfizer Inc. Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.4 Bayer AG

16.4.1 Bayer AG Company Profile

16.4.2 Bayer AG Recombinant Vaccines Product Specification

16.4.3 Bayer AG Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.5 Sanofi S A.

16.5.1 Sanofi S A. Company Profile

16.5.2 Sanofi S A. Recombinant Vaccines Product Specification

16.5.3 Sanofi S A. Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.6 Protein Science Corporation

16.6.1 Protein Science Corporation Company Profile

16.6.2 Protein Science Corporation Recombinant Vaccines Product Specification

16.6.3 Protein Science Corporation Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.7 GlaxoSmithKline Plc.

16.7.1 GlaxoSmithKline Plc. Company Profile

16.7.2 GlaxoSmithKline Plc. Recombinant Vaccines Product Specification

16.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.8 Novartis AG

16.8.1 Novartis AG Company Profile

16.8.2 Novartis AG Recombinant Vaccines Product Specification

16.8.3 Novartis AG Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

16.9 Bharat Biotech

16.9.1 Bharat Biotech Company Profile

16.9.2 Bharat Biotech Recombinant Vaccines Product Specification

16.9.3 Bharat Biotech Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

17 Recombinant Vaccines Manufacturing Cost Analysis

17.1 Recombinant Vaccines Key Raw Materials Analysis

17.1.1 Key Raw Materials

17.2 Proportion of Manufacturing Cost Structure

17.3 Manufacturing Process Analysis of Recombinant Vaccines

17.4 Recombinant Vaccines Industrial Chain Analysis

18 Marketing Channel, Distributors and Customers

18.1 Marketing Channel

18.2 Recombinant Vaccines Distributors List

18.3 Recombinant Vaccines Customers

19 Market Dynamics

19.1 Market Trends

19.2 Opportunities and Drivers

19.3 Challenges

19.4 Porter's Five Forces Analysis

20 Production and Supply Forecast

20.1 Global Forecasted Production of Recombinant Vaccines (2022-2027)

20.2 Global Forecasted Revenue of Recombinant Vaccines (2022-2027)

20.3 Global Forecasted Price of Recombinant Vaccines (2016-2027)

20.4 Global Forecasted Production of Recombinant Vaccines by Region (2022-2027)

20.4.1 North America Recombinant Vaccines Production, Revenue Forecast (2022-2027)

20.4.2 East Asia Recombinant Vaccines Production, Revenue Forecast (2022-2027)

20.4.3 Europe Recombinant Vaccines Production, Revenue Forecast (2022-2027)

20.4.4 South Asia Recombinant Vaccines Production, Revenue Forecast (2022-2027)

20.4.5 Southeast Asia Recombinant Vaccines Production, Revenue Forecast (2022-2027)

20.4.6 Middle East Recombinant Vaccines Production, Revenue Forecast (2022-2027)

20.4.7 Africa Recombinant Vaccines Production, Revenue Forecast (2022-2027)

20.4.8 Oceania Recombinant Vaccines Production, Revenue Forecast (2022-2027)

20.4.9 South America Recombinant Vaccines Production, Revenue Forecast (2022-2027)

20.4.10 Rest of the World Recombinant Vaccines Production, Revenue Forecast (2022-2027)

20.5 Forecast by Type and by Application (2022-2027)

20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

20.5.2 Global Forecasted Consumption of Recombinant Vaccines by Application (2022-2027)

21 Consumption and Demand Forecast

21.1 North America Forecasted Consumption of Recombinant Vaccines by Country

21.2 East Asia Market Forecasted Consumption of Recombinant Vaccines by Country

21.3 Europe Market Forecasted Consumption of Recombinant Vaccines by Countriy

21.4 South Asia Forecasted Consumption of Recombinant Vaccines by Country

21.5 Southeast Asia Forecasted Consumption of Recombinant Vaccines by Country

21.6 Middle East Forecasted Consumption of Recombinant Vaccines by Country

21.7 Africa Forecasted Consumption of Recombinant Vaccines by Country

21.8 Oceania Forecasted Consumption of Recombinant Vaccines by Country

21.9 South America Forecasted Consumption of Recombinant Vaccines by Country

21.10 Rest of the world Forecasted Consumption of Recombinant Vaccines by Country

22 Research Findings and Conclusion

23 Methodology and Data Source

23.1 Methodology/Research Approach

23.1.1 Research Programs/Design

23.1.2 Market Size Estimation

23.1.3 Market Breakdown and Data Triangulation

23.2 Data Source

23.2.1 Secondary Sources

23.2.2 Primary Sources

23.3 Disclaimer



List of Figure

Key Players Covered: Ranking by Recombinant Vaccines Revenue (US$ Million) 2016-2021

Global Recombinant Vaccines Market Size by Type (US$ Million): 2022-2027

Global Recombinant Vaccines Market Size by Application (US$ Million): 2022-2027

Global Recombinant Vaccines Production Capacity by Manufacturers

Global Recombinant Vaccines Production by Manufacturers (2016-2021)

Global Recombinant Vaccines Production Market Share by Manufacturers (2016-2021)

Global Recombinant Vaccines Revenue by Manufacturers (2016-2021)

Global Recombinant Vaccines Revenue Share by Manufacturers (2016-2021)

Global Market Recombinant Vaccines Average Price of Key Manufacturers (2016-2021)

Manufacturers Recombinant Vaccines Production Sites and Area Served

Manufacturers Recombinant Vaccines Product Type

Global Recombinant Vaccines Sales Volume by Region (2016-2021)

Global Recombinant Vaccines Sales Volume Market Share by Region (2016-2021)

Global Recombinant Vaccines Sales Revenue by Region (2016-2021)

Global Recombinant Vaccines Sales Revenue Market Share by Region (2016-2021)

North America Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

East Asia Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Europe Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

South Asia Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Southeast Asia Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Middle East Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Africa Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Oceania Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

South America Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

Rest of the World Recombinant Vaccines Sales Volume Capacity, Revenue, Price and Gross Margin (2016-2021)

North America Recombinant Vaccines Consumption by Countries (2016-2021)

East Asia Recombinant Vaccines Consumption by Countries (2016-2021)

Europe Recombinant Vaccines Consumption by Region (2016-2021)

South Asia Recombinant Vaccines Consumption by Countries (2016-2021)

Southeast Asia Recombinant Vaccines Consumption by Countries (2016-2021)

Middle East Recombinant Vaccines Consumption by Countries (2016-2021)

Africa Recombinant Vaccines Consumption by Countries (2016-2021)

Oceania Recombinant Vaccines Consumption by Countries (2016-2021)

South America Recombinant Vaccines Consumption by Countries (2016-2021)

Rest of the World Recombinant Vaccines Consumption by Countries (2016-2021)

Global Recombinant Vaccines Sales Volume by Type (2016-2021)

Global Recombinant Vaccines Sales Volume Market Share by Type (2016-2021)

Global Recombinant Vaccines Sales Revenue by Type (2016-2021)

Global Recombinant Vaccines Sales Revenue Share by Type (2016-2021)

Global Recombinant Vaccines Sales Price by Type (2016-2021)

Global Recombinant Vaccines Consumption Volume by Application (2016-2021)

Global Recombinant Vaccines Consumption Volume Market Share by Application (2016-2021)

Global Recombinant Vaccines Consumption Value by Application (2016-2021)

Global Recombinant Vaccines Consumption Value Market Share by Application (2016-2021)

Merck & Co., Inc Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Green Cross Corporation Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Pfizer Inc. Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table Bayer AG Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Sanofi S A. Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Protein Science Corporation Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

GlaxoSmithKline Plc. Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Novartis AG Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Bharat Biotech Recombinant Vaccines Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Recombinant Vaccines Distributors List

Recombinant Vaccines Customers List

Market Key Trends

Key Opportunities and Drivers: Impact Analysis (2022-2027)

Key Challenges

Global Recombinant Vaccines Production Forecast by Region (2022-2027)

Global Recombinant Vaccines Sales Volume Forecast by Type (2022-2027)

Global Recombinant Vaccines Sales Volume Market Share Forecast by Type (2022-2027)

Global Recombinant Vaccines Sales Revenue Forecast by Type (2022-2027)

Global Recombinant Vaccines Sales Revenue Market Share Forecast by Type (2022-2027)

Global Recombinant Vaccines Sales Price Forecast by Type (2022-2027)

Global Recombinant Vaccines Consumption Volume Forecast by Application (2022-2027)

Global Recombinant Vaccines Consumption Value Forecast by Application (2022-2027)

North America Recombinant Vaccines Consumption Forecast 2022-2027 by Country

East Asia Recombinant Vaccines Consumption Forecast 2022-2027 by Country

Europe Recombinant Vaccines Consumption Forecast 2022-2027 by Country

South Asia Recombinant Vaccines Consumption Forecast 2022-2027 by Country

Southeast Asia Recombinant Vaccines Consumption Forecast 2022-2027 by Country

Middle East Recombinant Vaccines Consumption Forecast 2022-2027 by Country

Africa Recombinant Vaccines Consumption Forecast 2022-2027 by Country

Oceania Recombinant Vaccines Consumption Forecast 2022-2027 by Country

South America Recombinant Vaccines Consumption Forecast 2022-2027 by Country

Rest of the world Recombinant Vaccines Consumption Forecast 2022-2027 by Country

Research Programs/Design for This Report

Key Data Information from Secondary Sources

Key Data Information from Primary Sources





Global Recombinant Vaccines Market Share by Type: 2021 VS 2027

Subunit Recombinant Vaccines Features

Attenuated Recombinant Vaccines Features

Vector Recombinant Vaccines Features

Global Recombinant Vaccines Market Share by Application: 2021 VS 2027

Recombinant Human Vaccines Case Studies

Animal Recombinant Vaccines Case Studies

Recombinant Vaccines Report Years Considered

Global Recombinant Vaccines Market Status and Outlook (2016-2027)

North America Recombinant Vaccines Revenue (Value) and Growth Rate (2016-2027)

East Asia Recombinant Vaccines Revenue (Value) and Growth Rate (2016-2027)

Europe Recombinant Vaccines Revenue (Value) and Growth Rate (2016-2027)

South Asia Recombinant Vaccines Revenue (Value) and Growth Rate (2016-2027)

South America Recombinant Vaccines Revenue (Value) and Growth Rate (2016-2027)

Middle East Recombinant Vaccines Revenue (Value) and Growth Rate (2016-2027)

Africa Recombinant Vaccines Revenue (Value) and Growth Rate (2016-2027)

Oceania Recombinant Vaccines Revenue (Value) and Growth Rate (2016-2027)

South America Recombinant Vaccines Revenue (Value) and Growth Rate (2016-2027)

Rest of the World Recombinant Vaccines Revenue (Value) and Growth Rate (2016-2027)

North America Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

East Asia Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

Europe Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

South Asia Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

Southeast Asia Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

Middle East Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

Africa Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

Oceania Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

South America Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

Rest of the World Recombinant Vaccines Sales Volume Growth Rate (2016-2021)

North America Recombinant Vaccines Consumption and Growth Rate (2016-2021)

North America Recombinant Vaccines Consumption Market Share by Countries in 2021

United States Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Canada Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Mexico Recombinant Vaccines Consumption and Growth Rate (2016-2021)

East Asia Recombinant Vaccines Consumption and Growth Rate (2016-2021)

East Asia Recombinant Vaccines Consumption Market Share by Countries in 2021

China Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Japan Recombinant Vaccines Consumption and Growth Rate (2016-2021)

South Korea Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Europe Recombinant Vaccines Consumption and Growth Rate

Europe Recombinant Vaccines Consumption Market Share by Region in 2021

Germany Recombinant Vaccines Consumption and Growth Rate (2016-2021)

United Kingdom Recombinant Vaccines Consumption and Growth Rate (2016-2021)

France Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Italy Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Russia Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Spain Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Netherlands Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Switzerland Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Poland Recombinant Vaccines Consumption and Growth Rate (2016-2021)

South Asia Recombinant Vaccines Consumption and Growth Rate

South Asia Recombinant Vaccines Consumption Market Share by Countries in 2021

India Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Pakistan Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Bangladesh Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Southeast Asia Recombinant Vaccines Consumption and Growth Rate

Southeast Asia Recombinant Vaccines Consumption Market Share by Countries in 2021

Indonesia Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Thailand Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Singapore Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Malaysia Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Philippines Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Vietnam Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Myanmar Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Middle East Recombinant Vaccines Consumption and Growth Rate

Middle East Recombinant Vaccines Consumption Market Share by Countries in 2021

Turkey Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Saudi Arabia Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Iran Recombinant Vaccines Consumption and Growth Rate (2016-2021)

United Arab Emirates Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Israel Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Iraq Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Qatar Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Kuwait Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Oman Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Africa Recombinant Vaccines Consumption and Growth Rate

Africa Recombinant Vaccines Consumption Market Share by Countries in 2021

Nigeria Recombinant Vaccines Consumption and Growth Rate (2016-2021)

South Africa Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Egypt Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Algeria Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Morocco Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Oceania Recombinant Vaccines Consumption and Growth Rate

Oceania Recombinant Vaccines Consumption Market Share by Countries in 2021

Australia Recombinant Vaccines Consumption and Growth Rate (2016-2021)

New Zealand Recombinant Vaccines Consumption and Growth Rate (2016-2021)

South America Recombinant Vaccines Consumption and Growth Rate

South America Recombinant Vaccines Consumption Market Share by Countries in 2021

Brazil Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Argentina Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Columbia Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Chile Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Venezuelal Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Peru Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Puerto Rico Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Ecuador Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Rest of the World Recombinant Vaccines Consumption and Growth Rate

Rest of the World Recombinant Vaccines Consumption Market Share by Countries in 2021

Kazakhstan Recombinant Vaccines Consumption and Growth Rate (2016-2021)

Sales Market Share of Recombinant Vaccines by Type in 2021

Sales Revenue Market Share of Recombinant Vaccines by Type in 2021

Global Recombinant Vaccines Consumption Volume Market Share by Application in 2021

Merck & Co., Inc Recombinant Vaccines Product Specification

Green Cross Corporation Recombinant Vaccines Product Specification

Pfizer Inc. Recombinant Vaccines Product Specification

Bayer AG Recombinant Vaccines Product Specification

Sanofi S A. Recombinant Vaccines Product Specification

Protein Science Corporation Recombinant Vaccines Product Specification

GlaxoSmithKline Plc. Recombinant Vaccines Product Specification

Novartis AG Recombinant Vaccines Product Specification

Bharat Biotech Recombinant Vaccines Product Specification

Manufacturing Cost Structure of Recombinant Vaccines

Manufacturing Process Analysis of Recombinant Vaccines

Recombinant Vaccines Industrial Chain Analysis

Channels of Distribution

Distributors Profiles

Porter's Five Forces Analysis

Global Recombinant Vaccines Production Capacity Growth Rate Forecast (2022-2027)

Global Recombinant Vaccines Revenue Growth Rate Forecast (2022-2027)

Global Recombinant Vaccines Price and Trend Forecast (2016-2027)

North America Recombinant Vaccines Production Growth Rate Forecast (2022-2027)

North America Recombinant Vaccines Revenue Growth Rate Forecast (2022-2027)

East Asia Recombinant Vaccines Production Growth Rate Forecast (2022-2027)

East Asia Recombinant Vaccines Revenue Growth Rate Forecast (2022-2027)

Europe Recombinant Vaccines Production Growth Rate Forecast (2022-2027)

Europe Recombinant Vaccines Revenue Growth Rate Forecast (2022-2027)

South Asia Recombinant Vaccines Production Growth Rate Forecast (2022-2027)

South Asia Recombinant Vaccines Revenue Growth Rate Forecast (2022-2027)

Southeast Asia Recombinant Vaccines Production Growth Rate Forecast (2022-2027)

Southeast Asia Recombinant Vaccines Revenue Growth Rate Forecast (2022-2027)

Middle East Recombinant Vaccines Production Growth Rate Forecast (2022-2027)

Middle East Recombinant Vaccines Revenue Growth Rate Forecast (2022-2027)

Africa Recombinant Vaccines Production Growth Rate Forecast (2022-2027)

Africa Recombinant Vaccines Revenue Growth Rate Forecast (2022-2027)

Oceania Recombinant Vaccines Production Growth Rate Forecast (2022-2027)

Oceania Recombinant Vaccines Revenue Growth Rate Forecast (2022-2027)

South America Recombinant Vaccines Production Growth Rate Forecast (2022-2027)

South America Recombinant Vaccines Revenue Growth Rate Forecast (2022-2027)

Rest of the World Recombinant Vaccines Production Growth Rate Forecast (2022-2027)

Rest of the World Recombinant Vaccines Revenue Growth Rate Forecast (2022-2027)

North America Recombinant Vaccines Consumption Forecast 2022-2027

East Asia Recombinant Vaccines Consumption Forecast 2022-2027

Europe Recombinant Vaccines Consumption Forecast 2022-2027

South Asia Recombinant Vaccines Consumption Forecast 2022-2027

Southeast Asia Recombinant Vaccines Consumption Forecast 2022-2027

Middle East Recombinant Vaccines Consumption Forecast 2022-2027

Africa Recombinant Vaccines Consumption Forecast 2022-2027

Oceania Recombinant Vaccines Consumption Forecast 2022-2027

South America Recombinant Vaccines Consumption Forecast 2022-2027

Rest of the world Recombinant Vaccines Consumption Forecast 2022-2027

Bottom-up and Top-down Approaches for This Report